2015 American Transplant Congress » Poster Session D: Viral Infections

Date: Tuesday, May 5, 2015

Time: 5:30pm-6:30pm

Location: Exhibit Hall E

Session Type: Poster Session

Meeting: 2015 American Transplant Congress

5:30pm-6:30pm: African American Race Is an Independent Risk Factor for Cytomegalovirus Infection in Renal Transplant Recipients on Low-Dose Valganciclovir Prophylaxis

S. Patel, S. Kuten, J. Loucks-DeVos, R. Knight, A. Gaber.

5:30pm-6:30pm: Boosting the Adaptive Immune Response Prevents the High Incidence of Herpes Zoster After Lung or Heart Transplantation

N. van Besouw,¹ S. Roest,² J. Zuijderwijk,¹ R. de Kuiper,¹ J. van Weezel,³ A. van der Eijk,⁴ W. Weimar,¹ P. Hal,³ O. Manintveld.²

5:30pm-6:30pm: CMV IgG Provides Similar Anti-CMV Efficacy as Valganciclovir in High-Risk Organ Transplant Recipients, With Reduced Costs

N. Pilch, D. Taber, C. Schaffner, S. Nadig, J. McGillicuddy, C. Bratton, P. Baliga, K. Chavin.

5:30pm-6:30pm: Changing Demographics of HIV+ Liver Transplant Candidates

C. Durand, S. Gustafson, J. Locke, J. Snyder, B. Shelton, R. Reed, P. MacLennan, S. Mehta, A. Nellore, D. Segev.

5:30pm-6:30pm: Cytomegalovirus and BK Infections in Sensitized Kidney Transplant Recipients

S. Parajuli, B. Muth, J. Turk, M. Mohamed, D. Mandelbrot, A. Djamali.

5:30pm-6:30pm: Dengue Virus Infection Among Renal Transplant Recipients: A Series of 10 Cases in a Tropical Country

S. Costa,^1,2 C. Jacinto,¹ L. Martiniano,¹ Y. Amaral,¹ F. Paes,² M. Sales,² E. Daher,^1,2 G. Junior,³ R. Esmeraldo.²

5:30pm-6:30pm: Favorable Long-Term Outcome of Late-Onset CMV Disease in D+R- Kidney Transplant Recipients Treated With Universal Prophylaxis

H. Kaminski,¹ L. Couzi,^1,2 I. Garrigue,^3,4 J. Déchanet-Merville,² P. Merville.^1,2

5:30pm-6:30pm: Geographic Differences in HIV+ Kidney Transplant Waitlist Characteristics

J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3

5:30pm-6:30pm: Human CMV-Specific CD8 T Cells Exhibit Distinct Phenotypes and Distribution Patterns in Tissues and Circulation

C. Gordon,^1,2,5 J. Thome,^1,3 G. Tomer,¹ D. Farber.^1,3,4

5:30pm-6:30pm: Implementation of Evidence-Based Guidelines for Cytomegalovirus Prevention in Pediatric Solid Organ Transplantation

L. Danziger-Isakov, T. Hemmelgarn, R. Kohli, D. Lazear, M. Lake, J. Goebel, C. Castleberry, J. Courter, S. Kacoshis, M. Schecter, D. Witte, E. Clark, J. Bucuvalas.

5:30pm-6:30pm: Incidence and Characteristics of CMV Infection in High Risk (D+R-) Kidney Transplant Recipients and the Utility of Monthly Surveillance After Routine Prophylaxis

M. Bhattarai, C. Puttarajappa, G. Mour, C. Wu, P. Sood, N. Shah, R. Mehta, A. Tevar, S. Hariharan.

5:30pm-6:30pm: Incidence of Hepatitis B Virus Reactivation in Kidney Transplant Patients Who Received Rituximab Administration

K. Omoto, M. Okumi, D. Toki, T. Shimizu, H. Ishida, K. Tanabe.

5:30pm-6:30pm: Low Dose Valganciclovir Prophylaxis Following Renal Transplantation With Steroid Free Immunosuppression

J. Chen,¹ A. Shah,² M. Sauer,¹ T. Taber,³ A. Sharfuddin,³ M. Yaqub,³ D. Mishler,³ J. Powelson,⁴ W. Goggins.⁴

5:30pm-6:30pm: Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients-A Single Center Experience

N. Alvey,¹ J. Tieman,¹ A. Diamond,² A. Hodowanec,¹ D. Simon,¹ S. Fayek,¹ M. Hertl,¹ O. Olaitan,¹ E. Hollinger,¹ E. Chan.¹

5:30pm-6:30pm: Racial Differences in Transplant and Waitlist Mortality Rates Among HIV+ Kidney Transplant Candidates

J. Locke,¹ S. Gustafson,² C. Durand,³ J. Snyder,² B. Shelton,¹ R. Reed,¹ P. MacLennan,¹ S. Mehta,¹ A. Nellore,¹ D. Segev.^2,3

5:30pm-6:30pm: Recurrent Cytomegalovirus Infection After Solid Organ Transplant

Y. Natori, A. Humar, S. Husain, C. Rotstein, D. Kumar.

5:30pm-6:30pm: Safety and Efficacy of Pegylated Interferon and Ribavirin for Chronic Hepatitis C Following Renal Transplantation

G. Chen, L. Zhu, S. Chen, X. Wang, Z. Lin.

5:30pm-6:30pm: Safety and Outcome of Ganciclovir-Resistant CMV Treated With Foscarnet: A Single Center Retrospective Study

B. Pierce,⁴ C. Richardson,⁴ K. Cunningham,⁴ C. D'Agostino,⁴ C. Tseng,⁴ J. Brown,⁴ C. O'Brien,⁴ B. Ho,^1,3,5 M. Ison.^1,2,3

5:30pm-6:30pm: Screening for West Nile Virus in California: Resolving IgM Anti-WNV in the Area With Dengue Seroprevalence

C. Chinchilla-Reyes,^1,2 D. Tanglao,¹ T. Mone,³ M. Koss,¹ M. Nowicki.^1,2

5:30pm-6:30pm: Survival Benefit of Liver Transplant Among HIV+ Waitlist Candidates

C. Durand,¹ S. Gustafson,² J. Locke,³ J. Snyder,² B. Shelton,³ R. Reed,³ P. MacLennan,³ S. Mehta,³ A. Nellore,³ D. Segev.^1,2

5:30pm-6:30pm: The Role of Antiviral Prophylaxis for the Prevention of Epstein-Barr Virus (EBV) Associated Post-Transplant Lymphoproliferative Disease (PTLD) in Solid Organ Transplant Recipients: A Systematic Review

M. AlDabbagh,^1,2 M. Gitman,³ D. Kumar, A. Humar, C. Rotstein, S. Husain.^1,3

« View all sessions from the 2015 American Transplant Congress